Market Place
Sourcing Support
Divi`s exits Nifty and gets `buy` recommendation with highest target
09 Oct 2024 //
CNBCTV18
Divis Laboratories reports Q1 FY25 consolidated PAT at Rs. 430 Cr
05 Aug 2024 //
ECONOMICSTIMES
Granules India`s Q1 profit nearly triples on strong demand
30 Jul 2024 //
REUTERS
U.S. FDA Inspects Divi`s Labs Facility In Visakhapatnam
19 Jul 2024 //
NDTV PROFIT
Divi`s Laboratories to expand capacity at an outlay of approx. Rs. 700 Cr
25 Apr 2024 //
INDINPHARMAPOST
Britannia most-loved, Divi’s Labs shunned by analysts in November
02 Dec 2022 //
MONEYCONTROL
Divi`s Lab falls over 1%, brokerages express concerns over growth sustainability
14 Feb 2022 //
CNBCTV18
Divi`s Labs tumbles more than 8% after Q2 numbers
07 Nov 2021 //
ECONOMICTIMES
India`s Divi`s Labs hits record high Merck`s +VE trial data for COVID-19 drug
02 Oct 2021 //
CHANNELNEWSASIA
Lack of valuation comfort may limit gains in Divi`s Laboratories stock
09 Aug 2021 //
BUSINESS-STANDARD
Divi`s Labs Q1 total income stood at Rs. 1.997 crore
09 Aug 2021 //
PHARMABIZ
Pharma shares in focus; Alkem, Divi`s Lab, Syngene hit record highs
15 Jul 2021 //
BUSINESS STANDARD
Divi`s Lab, Aurobindo Pharma: Are pharma stocks losing their sheen? Read on
10 Nov 2020 //
BUSINESS-STANDARD
Divi’s Labs posts strong performance; capex investment may boost bottomline
15 Sep 2020 //
PHARMABIZ
Divi`s Labs: APIs, custom synthesis, ongoing capex plan to support growth
21 Aug 2020 //
BUSINESS-STANDARD
Divi`s Laboratories, SBI Life Insurance shares gain on Nifty inclusion
21 Aug 2020 //
BUSINESS-STANDARD
Divi`s Labs beats drugmakers to become India`s 2nd most valuable pharma company
10 Aug 2020 //
LIVEMINT
Choke in API supplies from China creates huge opportunity for Divi`s Labs
26 Feb 2020 //
BUSINESS-STANDARD
Dr Reddy`s, Divi`s Lab, Torrent Pharma: What lies ahead for pharma stocks?
17 Feb 2020 //
BUSINESS-STANDARD
Divis Lab gets zero 483 observations from US FDA for AP facility
04 Feb 2020 //
PHARMABIZ
Divi`s Lab hits new high as Chippada unit gets zero USFDA observations
01 Feb 2020 //
BUSINESS-STANDARD
Divi`s Laboratories slips 9% on subdued June quarter results
12 Aug 2019 //
BUSINESS-STANDARD
Divi`s Labs falls 8% as Q4 profit misses Street estimates
27 May 2019 //
BUSINESS-STANDARD
Divis Laboratories on strong growth trend, experts expect margins to expand
22 Apr 2019 //
BUSINESS -STANDARD.COM/ARTICLE/MARKETS/D
Divi’s, Gland, Fidelity enter race to buy Orchid Pharma
04 Mar 2019 //
ECONOMIC TIMES
Income-Tax Department raids Divi`s Lab premises
20 Feb 2019 //
ECONOMIC TIMES
Income-Tax Department raids Divi`s Lab premises
19 Feb 2019 //
INDIATIMES
Pharma shares mixed; Divi`s Labs, Lupin shares in green
12 Oct 2018 //
ECONOMIC TIMES
Pharma stocks rise up to 4%; Cadila, Sun Pharma among top gainers
21 Aug 2018 //
ECONOMIC TIMES
Divi`s Labs gains 4% on successful USFDA inspection of Telangana unit
17 May 2018 //
BUSINESS STANDARD
Divi`s stock: Pricing pressure for drug makers can lead to more outsourcing
17 Apr 2018 //
BUSINESS-STANDARD
Divis to spend Rs 300 crore on expansion plans in 2018
30 Jan 2018 //
ECONOMIC TIMES
Pharma weekly wrap: Sector stocks stay weak on persistent US pricing pressure
12 Jan 2018 //
MONEYCONTROL
USFDA lifts import alert on Divi`s Labs` Vishakhapatnam unit
14 Nov 2017 //
BUSINESS-STANDARD
USFDA lifts import alert on Divi`s Laboratories unit
14 Nov 2017 //
MONEYCONTROL
Pharma stocks in pain; Aurobindo Pharma, Divi`s Lab among top losers
13 Nov 2017 //
ECONOMIC TIMES
Divi`s Labs gains as USFDA closes out warning letter for Vizag unit
09 Nov 2017 //
BUSINESS-STANARD
US FDA Issues Form 483 to Divi`s Laboratories Ltd. Unit II
27 Sep 2017 //
FDA
Resolved all issues leading to USFDA import alert on Vizag unit: Divis Labs
20 Sep 2017 //
BUSINESS-STANDARD
Divis Labs extend gains from Tuesday; other pharma stocks rally too
14 Sep 2017 //
MONEYCONTROL
Pharma shares extend gain; Sun Pharma, Divi`s Lab up over 10% in three days
13 Sep 2017 //
BUSINESS-STANDARD
Divi`s Lab gets green nod for Rs 100-cr modernisation project
14 Aug 2017 //
ECONOMIC TIMES
Buy Edelweiss, Titan; sell Sun Pharma, Granules India, Divis Labs Ashwani Gujral
09 Aug 2017 //
MONEYCONTROL
Tide turns for pharma as US FDA concerns get addressed
13 Jul 2017 //
BUSINESS-STANDARD
28 Unique Data Integrity Deficiencies That Aren’t Really Unique
02 Jun 2017 //
FDAZILLA
Divi`s Laboratories Ltd. (Unit II) Receives FDA Warning Letter
26 Apr 2017 //
FDA
Divis Labs hits 52-week low
24 Apr 2017 //
BUSNINESS-STANDARD
Divi`s weighs share buyback following sharp fall in share price
27 Mar 2017 //
BUSINESS-STANDARD
Divi`s Labs` Vizag plant banned from shipping to US
24 Mar 2017 //
IN PHARMATECHNOLOGIST
Divi`s Labs barred from exports to US after FDA import alert on Vizag unit
21 Mar 2017 //
BUSINESS-STANDARD
Pharma Stocks Come to a Halt on US Growth Downturn, Pricing Pressures
28 Dec 2016 //
FINANCIAL EXPRESS
Divi`s Lab to shift Rs 500 cr project if Kakinada protest not resolved
19 Dec 2016 //
BUSINESS STANDARD
Divi`s Laboratories Falls as Vizag Unit gets Five Observations from USFDA
08 Dec 2016 //
BUSINESS STANDARD
US FDA actions, DPCO hit sales & profits of top 30 cos in first half of 2016-17
21 Nov 2016 //
PHARMABIZ
Divi`s Laboratories` Clarification on News on Import Alert from US FDA
31 Aug 2016 //
PRESS RELEASE
Divis Pharmaceuticals Pvt Ltd On FDA Import Alert List
30 Aug 2016 //
FDA
Divis Labs Visakhapatnam Unit-2 has successful US FDA inspection
19 Feb 2016 //
ET HEALTHWORLD
Divis Laboratories files response to USFDA observations
09 Jan 2016 //
ECONOMIC TIMES
Divis Laboratories to Invest Rs 500 Crore to Set Up Manufacturing Plant
31 Jan 2015 //
THE ECONOMIC TIMES
